Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DERMAL FILLERS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 EPIDEMIOLOGY PROCEDURES PER COUNTRY
5 REGULATIONS OF NORTH AMERICA DERMAL FILLERS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES
6.1.2 INCREASING GERIATRIC POPULATION
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN DERMAL FILLERS
6.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AESTHETIC PROCEDURES
6.2.2 ESCALATING PRODUCT RECALL
6.2.3 FDA GUIDELINES FOR ADVANCED DERMAL FILLER INJECTORS
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE
6.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH
6.3.3 ADVANCEMENT IN THE NEW DERMAL FILLERS
6.3.4 INCREASING COMPENSATION AND ACCIDENTAL CLAIMS FOR DERMAL FILLER
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 AVAILABILITY OF ALTERNATIVES
7 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 BIODEGRADABLE DERMAL FILLERS
7.2.1 TEMPORARY BIODEGRADABLE
7.2.2 SEMI-PERMANENT BIODEGRADABLE
7.3 NON-BIODEGRADABLE DERMAL FILLERS
8 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE
8.1 OVERVIEW
8.2 NATURAL DERMAL FILLERS
8.2.1 HYALURONIC ACID
8.2.1.1 BY TYPE
8.2.1.1.1 MONOPHASIC FILLERS
8.2.1.2 BY TYPE
8.2.1.2.1 MONODENSIFIED
8.2.1.2.2 POLYDENSIFIED
8.2.1.2.3 BIPHASIC FILLERS
8.2.1.3 BY MATERIAL TYPE
8.2.1.3.1 SINGLE-PHASE
8.2.1.3.2 DUPLEX-PHASE
8.2.1.4 BY APPLICATION
8.2.1.4.1 FACE LIFT
8.2.1.4.2 RHINOPLASTY
8.2.1.4.3 RECONSTRUCTIVE SURGERY
8.2.1.4.4 FACIAL LINE CORRECTION
8.2.1.4.5 LIP ENHANCEMENT
8.2.1.4.6 SAGGING SKIN
8.2.1.4.7 CHEEK DEPRESSION
8.2.1.4.8 SKIN SMOOTHING
8.2.1.4.9 DENTISTRY
8.2.1.4.10 AESTHETIC RESTORATION
8.2.1.4.11 SCAR TREATMENT
8.2.1.4.12 CHIN AUGMENTATION
8.2.1.4.13 LIPOATROPHY TREATMENT
8.2.1.4.14 EARLOBE REJUVENATION
8.2.1.4.15 OTHERS
8.2.2 FAT
8.2.2.1 BY APPLICATION
8.2.2.1.1 FACE LIFT
8.2.2.1.2 RHINOPLASTY
8.2.2.1.3 RECONSTRUCTIVE SURGERY
8.2.2.1.4 FACIAL LINE CORRECTION
8.2.2.1.5 LIP ENHANCEMENT
8.2.2.1.6 SAGGING SKIN
8.2.2.1.7 CHEEK DEPRESSION
8.2.2.1.8 SKIN SMOOTHING
8.2.2.1.9 DENTISTRY
8.2.2.1.10 AESTHETIC RESTORATION
8.2.2.1.11 SCAR TREATMENT
8.2.2.1.12 CHIN AUGMENTATION
8.2.2.1.13 LIPOATROPHY TREATMENT
8.2.2.1.14 EARLOBE REJUVENATION
8.2.2.1.15 OTHERS
8.2.3 COLLAGEN
8.2.3.1 BY APPLICATION
8.2.3.1.1 FACE LIFT
8.2.3.1.2 RHINOPLASTY
8.2.3.1.3 RECONSTRUCTIVE SURGERY
8.2.3.1.4 FACIAL LINE CORRECTION
8.2.3.1.5 LIP ENHANCEMENT
8.2.3.1.6 SAGGING SKIN
8.2.3.1.7 CHEEK DEPRESSION
8.2.3.1.8 SKIN SMOOTHING
8.2.3.1.9 DENTISTRY
8.2.3.1.10 AESTHETIC RESTORATION
8.2.3.1.11 SCAR TREATMENT
8.2.3.1.12 CHIN AUGMENTATION
8.2.3.1.13 LIPOATROPHY TREATMENT
8.2.3.1.14 EARLOBE REJUVENATION
8.2.3.1.15 OTHERS
8.2.4 OTHERS
8.3 SYNTHETIC DERMAL FILLERS
8.3.1 POLY-L-LACTIC ACID
8.3.1.1 BY APPLICATION
8.3.1.1.1 FACE LIFT
8.3.1.1.2 RHINOPLASTY
8.3.1.1.3 RECONSTRUCTIVE SURGERY
8.3.1.1.4 FACIAL LINE CORRECTION
8.3.1.1.5 LIP ENHANCEMENT
8.3.1.1.6 SAGGING SKIN
8.3.1.1.7 CHEEK DEPRESSION
8.3.1.1.8 SKIN SMOOTHING
8.3.1.1.9 DENTISTRY
8.3.1.1.10 AESTHETIC RESTORATION
8.3.1.1.11 SCAR TREATMENT
8.3.1.1.12 CHIN AUGMENTATION
8.3.1.1.13 LIPOATROPHY TREATMENT
8.3.1.1.14 EARLOBE REJUVENATION
8.3.1.1.15 OTHERS
8.3.2 CALCIUM HYDROXYLAPATITE
8.3.2.1 BY APPLICATION
8.3.2.1.1 FACE LIFT
8.3.2.1.2 RHINOPLASTY
8.3.2.1.3 RECONSTRUCTIVE SURGERY
8.3.2.1.4 FACIAL LINE CORRECTION
8.3.2.1.5 LIP ENHANCEMENT
8.3.2.1.6 SAGGING SKIN
8.3.2.1.7 CHEEK DEPRESSION
8.3.2.1.8 SKIN SMOOTHING
8.3.2.1.9 DENTISTRY
8.3.2.1.10 AESTHETIC RESTORATION
8.3.2.1.11 SCAR TREATMENT
8.3.2.1.12 CHIN AUGMENTATION
8.3.2.1.13 LIPOATROPHY TREATMENT
8.3.2.1.14 EARLOBE REJUVENATION
8.3.2.1.15 OTHERS
8.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
8.3.3.1 BY APPLICATION
8.3.3.1.1 FACE LIFT
8.3.3.1.2 RHINOPLASTY
8.3.3.1.3 RECONSTRUCTIVE SURGERY
8.3.3.1.4 FACIAL LINE CORRECTION
8.3.3.1.5 LIP ENHANCEMENT
8.3.3.1.6 SAGGING SKIN
8.3.3.1.7 CHEEK DEPRESSION
8.3.3.1.8 SKIN SMOOTHING
8.3.3.1.9 DENTISTRY
8.3.3.1.10 AESTHETIC RESTORATION
8.3.3.1.11 SCAR TREATMENT
8.3.3.1.12 CHIN AUGMENTATION
8.3.3.1.13 LIPOATROPHY TREATMENT
8.3.3.1.14 EARLOBE REJUVENATION
8.3.3.1.15 OTHERS
8.3.4 POLYALKYLIMIDE
8.3.4.1 BY APPLICATION
8.3.4.1.1 FACE LIFT
8.3.4.1.2 RHINOPLASTY
8.3.4.1.3 RECONSTRUCTIVE SURGERY
8.3.4.1.4 FACIAL LINE CORRECTION
8.3.4.1.5 LIP ENHANCEMENT
8.3.4.1.6 SAGGING SKIN
8.3.4.1.7 CHEEK DEPRESSION
8.3.4.1.8 SKIN SMOOTHING
8.3.4.1.9 DENTISTRY
8.3.4.1.10 AESTHETIC RESTORATION
8.3.4.1.11 SCAR TREATMENT
8.3.4.1.12 CHIN AUGMENTATION
8.3.4.1.13 LIPOATROPHY TREATMENT
8.3.4.1.14 EARLOBE REJUVENATION
8.3.4.1.15 OTHERS
8.3.5 OTHERS
9 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FACE LIFT
9.2.1 DEEP PLANE/SMAS FACE
9.2.2 MINI FACE LIFT
9.2.3 MID-FACE LIFT
9.2.4 JAW LINE
9.2.5 CUTANEOUS LIFT
9.2.6 TEMPORAL OR BROW LIFT
9.2.7 LIQUID FACE LIFT
9.2.8 OTHERS
9.2.8.1 JUVEDERM
9.2.8.2 RESTYLANE
9.2.8.3 SCULPTRA
9.2.8.4 DYSPORT
9.2.8.5 OTHERS
9.3 RHINOPLASTY
9.3.1 JUVEDERM
9.3.1.1 JUVEDERM XC
9.3.1.2 JUVEDERM ULTRA XC
9.3.1.3 JUVEDERM VOLUMA
9.3.1.4 JUVEDERM VOLBELLA
9.3.1.5 JUVEDERM VOLLURE XC
9.3.2 RESTYLANE
9.3.2.1 RESTYLANE SILK
9.3.2.2 RESTYLANE LYFT
9.3.2.3 RESTYLANE REFYNE
9.3.2.4 RESTYLANE DEFYNE
9.3.2.5 RESTYLANE-L
9.3.3 OTHERS
9.4 RECONSTRUCTIVE SURGERY
9.4.1 JUVEDERM
9.4.2 RESTYLANE
9.4.3 OTHERS
9.5 FACIAL LINE CORRECTION
9.5.1 DYNAMIC WRINKLES
9.5.2 STATIC WRINKLES
9.5.3 WRINKLE FOLDS
9.5.3.1 FOREHEAD LINES
9.5.3.2 WORRY LINES
9.5.3.3 BUNNIES
9.5.3.4 CROW’S FEET
9.5.3.5 LAUGH LINES
9.5.3.6 LIP LINES
9.5.3.7 MARIONETTE LINES
9.5.3.8 OTHERS
9.5.3.8.1 JUVEDERM
9.5.3.8.2 RESTYLANE
9.5.3.8.3 RADIESSE
9.5.3.8.4 BELOTERO
9.5.3.8.5 OTHERS
9.6 LIP ENHANCEMENT
9.6.1 JUVEDERM
9.6.1.1 JUVÉDERM XC
9.6.1.2 JUVÉDERM ULTRA XC
9.6.1.3 JUVÉDERM VOLUMA
9.6.1.4 JUVÉDERM VOLBELLA
9.6.1.5 JUVÉDERM VOLLURE XC
9.6.2 RESTYLANE
9.6.2.1 RESTYLANE SILK
9.6.2.2 RESTYLANE LYFT
9.6.2.3 RESTYLANE REFYNE
9.6.2.4 RESTYLANE DEFYNE
9.6.2.5 RESTYLANE-L
9.6.3 BELOTERO BALANCE
9.6.4 REVANESSE VERSA
9.6.5 HYLAFORM
9.6.6 PREVELLE SILK
9.6.7 OTHERS
9.7 SAGGING SKIN
9.7.1 JUVEDERM
9.7.2 RESTYLANE
9.7.3 BELOTERO
9.7.4 OTHERS
9.8 CHEEK DEPRESSION
9.8.1 JUVEDERM VOLUMA
9.8.2 RESTYLANE-LYFT
9.8.3 SCULPTRA
9.8.4 RADIESSE
9.8.5 OTHERS
9.9 SKIN SMOOTHENING
9.9.1 RESTYLANE
9.9.2 BELOTERO
9.9.3 BELLAFIL
9.9.4 OTHERS
9.1 DENTISTRY
9.10.1 JUVEDERM
9.10.2 RESTYLANE
9.10.3 RADIESSE
9.10.4 OTHERS
9.11 AESTHETIC RESTORATION
9.11.1 JUVEDERM
9.11.1.1 JUVEDERM ULTRA XC
9.11.1.2 JUVEDERM VOLLURE XC
9.11.1.3 JUVEDERM VOLBELLA XC
9.11.2 RESTYLANE
9.11.2.1 RESTYLANE-L
9.11.2.2 RESTYLANE SILK
9.11.2.3 RESTYLANE REFYNE AND DEFYNE
9.11.2.4 RESTYLANE LYFT
9.12 REVANESSE VERSA
9.13 SCULPTRA
9.14 RHA
9.14.1 RHA 2
9.14.2 RHA 3
9.14.3 RHA 4
9.15 BELLAFIL
9.16 BELOTERO BALANCE
9.17 OTHERS
9.18 LIP PLUM
9.18.1 RESTYLANE
9.18.2 BELOTERO
9.18.3 OTHERS
9.19 SCAR TREATMENT
9.19.1 JUVEDERM
9.19.2 RESTYLANE
9.19.3 RADIESSE
9.19.4 BELOTERO
9.19.5 PERLANE
9.19.6 OTHERS
9.19.6.1 KELOID SCARS
9.19.6.2 CONTRACTURE SCARS
9.19.6.3 HYPERTROPHIC SCARS
9.19.6.4 ACNE SCARS
9.19.6.5 OTHERS
9.2 CHIN AUGMENTATION
9.20.1 JUVEDERM VOLUMA XC
9.20.2 RESTYLANE
9.20.3 OTHERS
9.21 LIPOATROPHY TREATMENT
9.21.1 SCULPTRA
9.21.2 OTHERS
9.22 EARLOBE REJUVENATION
9.22.1 JUVEDERM
9.22.2 RESTYLANE
9.22.3 SCULPTRA
9.22.4 BELOTERO
9.22.5 ELLANSE
9.22.6 OTHERS
9.23 OTHERS
10 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.1.1 JUVÉDERM XC
10.2.1.2 JUVÉDERM ULTRA XC
10.2.1.3 JUVÉDERM ULTRA PLUS XC
10.2.1.4 JUVÉDERM VOLBELLA
10.2.1.5 JUVÉDERM VOLUMA
10.2.1.6 JUVÉDERM VOLLURE
10.2.2 RESTYLANE
10.2.2.1 RESTYLANE-L
10.2.2.2 RESTYLANE REFYNE
10.2.2.3 RESTYLANE DEFYNE
10.2.2.4 RESTYLANE LYFT
10.2.2.5 RESTYLANE SILK
10.2.2.6 RESTYLANE KYSSE
10.2.2.7 RESTYLANE CONTOUR
10.2.3 RADIESSE
10.2.4 SCULPTRA
10.2.5 ELLANSE
10.2.5.1 ELLANSE-S
10.2.5.2 ELLANSE-M
10.2.5.3 ELLANSE-L
10.2.5.4 ELLANSE-E
10.2.6 BELLAFILL
10.2.7 AQUAMID
10.2.8 OTHERS
10.3 GENERIC
11 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER
11.1 OVERVIEW
11.2 DERMATOLOGY CLINICS
11.3 HOSPITALS
11.4 AMBULATORY SURGICAL CENTERS
11.5 ACADEMIC RESEARCH INSTITUTES
11.6 OTHERS
12 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 DRUG STORES
12.4 RETAIL PHARMACY
12.5 ONLINE PHARMACY
12.6 OTHERS
13 NORTH AMERICA DERMAL FILLERS MARKET, BY GEOGRAPHY
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA DERMA FILLERS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 GALDERMA LABORATORIES, L.P
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 MERZ NORTH AMERICA, INC (A SUBSIDIARY OF MERZ PHARMA)
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE)
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 REVANCE THERAPEUTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AMALIAN
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ANIKA THERAPEUTICS, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BIOPLUS CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BIOXIS PHARMACEUTICALS
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CONTURA INTERNATIONAL LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CROMA-PHARMA GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 DSM
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FILLMED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 GIVAUDAN
16.14.1 COMPANY SNAPSHOT
16.14.2 RECENT FINANCIALS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 HUMEDIX (A SUBSIDIARY OF HUONS NORTH AMERICA)
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 IBSA FARMACEUTICI ITALIA SRL (A SUBSIDIARY OF IBSA INSTITUT BIOCHIMIQUE SA)
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IPSEN PHARMA.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 MEDYTROX
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 MESOESTETIC
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 PROLLENIUM MEDICAL TECHNOLOGIES
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SOSUM NORTH AMERICA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 SUNEVA MEDICAL
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 TEOXANE SA
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 ZIMMER AESTHETICS
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 COST OF DERMAL FILLERS
TABLE 2 COST OF PROCEDURE
TABLE 3 ASAPS PROCEDURE FACTS
TABLE 4 COMPENSATION COST FOR DERMAL FILLERS
TABLE 5 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 7 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 10 NORTH AMERICA NON-BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA MONOPHASIC FILLERS IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA FAT IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA COLLAGEN IN DERMAL FILLERS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 20 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA POLY-L-LACTIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA CALCIUM HYDROXYLAPATITE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA POLYALKYLIMIDE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 29 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 38 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 39 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA RHA IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 60 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 61 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 63 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 64 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 65 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 66 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 67 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 68 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 69 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 70 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 71 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 72 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 73 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 74 NORTH AMERICA ELLANSE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 75 NORTH AMERICA GENERIC IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 76 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 NORTH AMERICA DERMATOLOGY CLINICS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 78 NORTH AMERICA HOSPITALS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 79 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 80 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 81 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 82 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 NORTH AMERICA DIRECT TENDER IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 84 NORTH AMERICA DRUG STORES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 85 NORTH AMERICA RETAIL PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 86 NORTH AMERICA ONLINE PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 87 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DERMAL FILLERS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DERMAL FILLERS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DERMAL FILLERS MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DERMAL FILLERS MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DERMAL FILLERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA DERMAL FILLERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA DERMAL FILLERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA DERMAL FILLERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR ANTI-AGING DRUGS, AND GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES ARE EXPECTED TO DRIVE THE NORTH AMERICA DERMAL FILLERS MARKET IN THE FORECAST PERIOD 2022 TO 2029
FIGURE 12 BIODEGRADABLE DERMAL FILLER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DERMAL FILLERS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA DERMAL FILLERS MARKET
FIGURE 14 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, 2021
FIGURE 19 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2021
FIGURE 23 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA DERMAL FILLERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, 2021
FIGURE 27 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2021
FIGURE 31 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA DERMAL FILLERS MARKET: SNAPSHOT (2021)
FIGURE 39 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021)
FIGURE 40 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 41 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 42 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 43 NORTH AMERICA DERMA FILLERS MARKET: COMPANY SHARE 2021 (%)
